The Companies and Markets show: GSK, Private Equity Trusts, and two more hot Aim stocks
On this week's episode, Dan Jones welcomes Jennifer Johnson to talk GlaxoSmithKline (GSK) - they've made a good start to life post Haleon split, but are they a one-trick pony at the moment? Then Mark Robinson dives back into the Aim 100, with two more interesting stocks from our special review of the top 100 companies…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Investors' Chronicle
See all episodes →
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.